"Satralizumab treatment in patients with AQP4-IgG–seropositive neuromye" by Hesham Abboud, Brian Steingo et al.
 

Satralizumab treatment in patients with AQP4-IgG–seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case series

Publication/Presentation Date

3-2025

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article

Share

COinS